However, cinacalcet is not always effective in all hyperparathyroidism patients, such as those with congenital CaSR mutations causing familial hypocalciuric hypercalcemia or neonatal hypoparathyroidism [40, 41]. Here, CASR is linked to hyperparathyroidism.